| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/CID/CIU701 |
| P698 | PubMed publication ID | 25182245 |
| P50 | author | Maria Prins | Q89373527 |
| Ineke G Stolte | Q89373944 | ||
| Peter Reiss | Q92970863 | ||
| P2093 | author name string | Suzanne E Geerlings | |
| Neeltje A Kootstra | |||
| AGEhIV Cohort Study Group | |||
| Ferdinand W Wit | |||
| Marc van der Valk | |||
| Judith Schouten | |||
| P2860 | cites work | C-Reactive Protein, Interleukin-6, and Fibrinogen as Predictors of Coronary Heart Disease | Q57605886 |
| Diagnosis and classification of diabetes mellitus | Q22255452 | ||
| Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies | Q24597052 | ||
| Human ZMPSTE24 disease mutations: residual proteolytic activity correlates with disease severity | Q24611268 | ||
| HIV infection and the risk of acute myocardial infarction | Q27347231 | ||
| Inflammatory and coagulation biomarkers and mortality in patients with HIV infection | Q28473903 | ||
| Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators | Q29547281 | ||
| Systemic effects of inflammation on health during chronic HIV infection | Q33577551 | ||
| Is HIV a model of accelerated or accentuated aging? | Q33792651 | ||
| Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection | Q33857515 | ||
| HIV Infection, Inflammation, Immunosenescence, and Aging | Q34150710 | ||
| Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007 | Q34348772 | ||
| HIV protease inhibitors do not cause the accumulation of prelamin A in PBMCs from patients receiving first line therapy: the ANRS EP45 "aging" study | Q34534986 | ||
| Plasma levels of soluble CD14 independently predict mortality in HIV infection | Q34764002 | ||
| Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions | Q35088160 | ||
| Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies | Q35169664 | ||
| Carotid intimal medial thickness in human immunodeficiency virus-infected women: effects of protease inhibitor use, cardiac risk factors, and the metabolic syndrome | Q35492436 | ||
| HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group | Q36147395 | ||
| HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation | Q36383621 | ||
| Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008. | Q36661756 | ||
| HIV-protease inhibitors block the enzymatic activity of purified Ste24p. | Q36892342 | ||
| Comparison of ischemic stroke incidence in HIV-infected and non-HIV-infected patients in a US health care system | Q36894824 | ||
| Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system | Q36938343 | ||
| Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity? | Q36942966 | ||
| A reference standard for the description of osteoporosis | Q37052404 | ||
| HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity | Q37378238 | ||
| Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease | Q37390635 | ||
| Persistent microbial translocation and immune activation in HIV-1-infected South Africans receiving combination antiretroviral therapy. | Q42970792 | ||
| Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study | Q43552952 | ||
| Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction | Q43678570 | ||
| Incidence of low and high-energy fractures in persons with and without HIV infection: a Danish population-based cohort study | Q43874625 | ||
| Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population | Q44503156 | ||
| Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study | Q44518022 | ||
| High rates of AIDS-related mortality among older adults in rural Kenya | Q45410651 | ||
| Survival of persons with and without HIV infection in Denmark, 1995-2005. | Q50544706 | ||
| Risk of cerebrovascular events in persons with and without HIV: a Danish nationwide population-based cohort study. | Q50553891 | ||
| Premature age-related comorbidities among HIV-infected persons compared with the general population. | Q51000618 | ||
| Recommendations for blood pressure measurement in humans: an AHA scientific statement from the Council on High Blood Pressure Research Professional and Public Education Subcommittee. | Q51538239 | ||
| Ischemic Heart Disease in HIV-Infected and HIV-Uninfected Individuals: A Population-Based Cohort Study | Q57300568 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | comorbidity | Q1414874 |
| P304 | page(s) | 1787-1797 | |
| P577 | publication date | 2014-09-02 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study | |
| P478 | volume | 59 |
| Q30361248 | 3D scattering transforms for disease classification in neuroimaging. |
| Q54211761 | A Review of Long-Term Toxicity of Antiretroviral Treatment Regimens and Implications for an Aging Population. |
| Q97692620 | A comparative analysis of blood pressure in HIV-infected patients versus uninfected controls residing in Sub-Saharan Africa: a narrative review |
| Q38607635 | A first-in-human study of the novel HIV-fusion inhibitor C34-PEG4-Chol |
| Q47638453 | Abnormal Lung Function in HIV-infected Adults: An Under-recognized Risk Factor for Early Mortality |
| Q56991795 | Achieving the fourth 90: healthy aging for people living with HIV |
| Q55949993 | Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society— Lancet Commission |
| Q59357369 | Aging and Apolipoprotein E in HIV Infection |
| Q50072732 | Aging in HIV-Infected Subjects: A New Scenario and a New View |
| Q35393050 | Aging with HIV vs. HIV seroconversion at older age: a diverse population with distinct comorbidity profiles |
| Q59798402 | Aging with HIV: what effect on mortality and loss to follow-up in the course of antiretroviral therapy? The IeDEA West Africa Cohort Collaboration |
| Q39176685 | Alcohol and dietary factors associate with gut integrity and inflammation in HIV-infected adults. |
| Q93196555 | Anti-HIV potency of T-cell responses elicited by dendritic cell therapeutic vaccination |
| Q58707534 | Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patients |
| Q89129214 | Association Between the 6-Minute Walk Test Distance and Peak Cardiorespiratory Fitness Among People Living with HIV Varies by Fitness Level |
| Q40045999 | Association between HIV and blood pressure in adults and role of body weight as a mediator: Cross-sectional study in Uganda |
| Q64134548 | Association between exposure to antiretroviral drugs and the incidence of hypertension in HIV-positive persons: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study |
| Q51763489 | Association of HIV Infection and Risk of Peripheral Artery Disease. |
| Q39086018 | Association of Kidney Function and Early Kidney Injury With Incident Hypertension in HIV-Infected Women |
| Q62035584 | Associations Between Antiretroviral Treatment and Avascular Bone Necrosis: The Swiss HIV Cohort Study |
| Q97644527 | Associations Between Plasma Immunomodulatory and Inflammatory Mediators With VACS Index Scores Among Older HIV-Infected Adults on Antiretroviral Therapy |
| Q55512254 | Asymptomatic HIV People Present Different Profiles of sCD14, sRAGE, DNA Damage, and Vitamins, according to the Use of cART and CD4+ T Cell Restoration. |
| Q42575470 | Beyond viral suppression of HIV - the new quality of life frontier |
| Q52596500 | Blood pressure and mortality in a prospective cohort of HIV-infected adults in Port-au-Prince, Haiti. |
| Q57180790 | British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015 |
| Q36671999 | CD4+/CD8+ ratio, age, and risk of serious noncommunicable diseases in HIV-infected adults on antiretroviral therapy |
| Q36219873 | CD4/CD8 Ratio and KT Ratio Predict Yellow Fever Vaccine Immunogenicity in HIV-Infected Patients |
| Q97520241 | COVID-19 and ethnicity: A novel pathophysiological role for inflammation |
| Q54219925 | Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study. |
| Q47651355 | Cardiovascular disease prevention policy in HIV: recommendations from a modelling study |
| Q90743449 | Cardiovascular risk factors in HIV infected individuals: Comparison with general adult control population in Greece |
| Q40523854 | Caring for Older Adults with the Human Immunodeficiency Virus. |
| Q91768229 | Chronic Disease Onset Among People Living with HIV and AIDS in a Large Private Insurance Claims Dataset |
| Q38821304 | Chronic Kidney Disease and Antiretroviral Therapy in HIV-Positive Individuals: Recent Developments |
| Q90985832 | Chronicity, ageing and multimorbidity |
| Q40523298 | Cigarette Smoking and Inflammation, Monocyte Activation, and Coagulation in HIV-Infected Individuals Receiving Antiretroviral Therapy, Compared With Uninfected Individuals |
| Q90550717 | Clinical management of ageing people living with HIV in Europe: the view of the care providers |
| Q97073462 | Cognitive disorders in people living with HIV |
| Q47290271 | Comorbidities Among US Patients With Prevalent HIV Infection-A Trend Analysis |
| Q55093102 | Comorbidities and co-medications in populations with and without chronic hepatitis C virus infection in Japan between 2015 and 2016. |
| Q55406947 | Comorbidities and the use of comedications in people living with HIV on antiretroviral therapy in Japan: a cross-sectional study using a hospital claims database. |
| Q47135424 | Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive antiretroviral therapy |
| Q89640150 | Consensus statement on the assessment of comorbidities in people living with HIV in Romania |
| Q57454891 | Construct validation of a Frailty Index, an HIV Index and a Protective Index from a clinical HIV database |
| Q37442717 | Copenhagen comorbidity in HIV infection (COCOMO) study: a study protocol for a longitudinal, non-interventional assessment of non-AIDS comorbidity in HIV infection in Denmark |
| Q92977500 | Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-experienced, virologically suppressed patients with HIV-1: subgroup analyses of the phase 3 EMERALD study |
| Q58782582 | Designing robot-assisted neurorehabilitation strategies for people with both HIV and stroke |
| Q55510378 | Diabetes mellitus in HIV-infected patients: fasting glucose, A1c, or oral glucose tolerance test - which method to choose for the diagnosis? |
| Q40051440 | Diagnostic challenges of kidney diseases in HIV-infected patients. |
| Q40267599 | Disability Among Middle-Aged and Older Persons With Human Immunodeficiency Virus Infection |
| Q57460846 | Do people living with HIV experience greater age advancement than their HIV-negative counterparts? |
| Q40203598 | Effect of Antiretroviral Therapy on Bone and Renal Health in Young Adults Infected With HIV in Early Life |
| Q38660325 | Effect of immediate initiation of antiretroviral treatment in HIV-positive individuals aged 50 years or older |
| Q47800071 | Efficacy and safety of dolutegravir and rilpivirine dual therapy as a simplification strategy: a cohort study |
| Q39097668 | Efficacy and safety of nucleoside-sparing regimen based on raltegravir and ritonavir-boosted darunavir in HIV-1-infected treatment-experienced patients. |
| Q93383858 | Elevated cerebrospinal fluid Galectin-9 is associated with central nervous system immune activation and poor cognitive performance in older HIV-infected individuals |
| Q38629009 | Epidemiology of ischemic heart disease in HIV. |
| Q38661423 | Evaluating patient preference and satisfaction for human immunodeficiency virus therapy in France |
| Q59357259 | Evaluation of Cardiovascular Disease Risk in HIV-1-Infected Patients Treated with Darunavir |
| Q47275628 | Excess Clinical Comorbidity Among HIV-Infected Patients Accessing Primary Care in US Community Health Centers |
| Q92277511 | Excess Risk for Atherosclerotic Cardiovascular Outcomes Among US Adults With HIV in the Current Era |
| Q92919704 | Frailty among HIV-1 Infected Adults under Antiretroviral Therapy in Indonesia |
| Q38654347 | Frontline Science: CXCR7 mediates CD14(+)CD16(+) monocyte transmigration across the blood brain barrier: a potential therapeutic target for NeuroAIDS. |
| Q91736512 | Fungal Translocation Is Associated with Immune Activation and Systemic Inflammation in Treated HIV |
| Q35925654 | Future challenges for clinical care of an ageing population infected with HIV: a modelling study |
| Q60049153 | Global and regional trends of people living with HIV aged 50 and over: Estimates and projections for 2000-2020 |
| Q57180752 | Gray and White Matter Abnormalities in Treated Human Immunodeficiency Virus Disease and Their Relationship to Cognitive Function |
| Q28073408 | Guidelines for Evaluation and Management of Cognitive Disorders in HIV-Positive Individuals |
| Q35907079 | HIV Associated Chronic Obstructive Pulmonary Disease in Nigeria |
| Q36299305 | HIV and Aging: Demographic Change in the Asia-Pacific Region |
| Q38883328 | HIV and ageing: improving quantity and quality of life. |
| Q96576975 | HIV and antiretroviral therapy-related fat alterations |
| Q92874950 | HIV antiretroviral drugs, dolutegravir, maraviroc and ritonavir-boosted atazanavir use different pathways to affect inflammation, senescence and insulin sensitivity in human coronary endothelial cells |
| Q57163408 | HIV infection follow-up, organisational and management model |
| Q41989794 | HIV primary care by the infectious disease physician in the United States - extending the continuum of care. |
| Q60921365 | HIV treatment regimens and adherence to national guidelines in Australia: an analysis of dispensing data from the Australian pharmaceutical benefits scheme |
| Q92234083 | HIV, antiretroviral therapy and non-communicable diseases in sub-Saharan Africa: empirical evidence from 44 countries over the period 2000 to 2016 |
| Q36986644 | HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial |
| Q94948243 | HIV-associated gut dysbiosis is independent of sexual practice and correlates with noncommunicable diseases |
| Q64229527 | HIV-related excess mortality and age-related comorbidities in patients with HIV aged ≥60: a relative survival analysis in the French Dat'AIDS cohort |
| Q56355650 | HIV: from exceptionalism to endgame |
| Q56960000 | High Cellular Monocyte Activation in People Living With Human Immunodeficiency Virus on Combination Antiretroviral Therapy and Lifestyle-Matched Controls Is Associated With Greater Inflammation in Cerebrospinal Fluid |
| Q119952866 | High-throughput proteomic analysis reveals systemic dysregulation in virally suppressed people living with HIV |
| Q41932859 | Higher Prevalence and Faster Progression of Chronic Kidney Disease in Human Immunodeficiency Virus-Infected Middle-Aged Individuals Compared With Human Immunodeficiency Virus-Uninfected Controls. |
| Q39796554 | Higher Prevalence of Hypertension in HIV-1-Infected Patients on Combination Antiretroviral Therapy Is Associated With Changes in Body Composition and Prior Stavudine Exposure |
| Q90262190 | Highlights from the 22nd International AIDS Conference (AIDS 2018), 22-27 July 2018, Amsterdam, the Netherlands |
| Q33442442 | Hospital admissions for HIV-infected prisoners in Italy |
| Q91638984 | How Monocytes Contribute to Increased Risk of Atherosclerosis in Virologically-Suppressed HIV-Positive Individuals Receiving Combination Antiretroviral Therapy |
| Q42778532 | How Underestimates of Need Contribute to Biased Conclusions |
| Q26740117 | Human Immunodeficiency Virus as a Chronic Disease: Evaluation and Management of Nonacquired Immune Deficiency Syndrome-Defining Conditions |
| Q40939137 | Human immunodeficiency virus and acquired immunodeficiency syndrome: recent developments and their implications for pediatric surgeons |
| Q38821848 | Hypertension Is a Key Feature of the Metabolic Syndrome in Subjects Aging with HIV |
| Q88732257 | Hypertension in HIV-Infected Adults: Novel Pathophysiologic Mechanisms |
| Q39661882 | Impact of age on care pathways of people living with HIV followed up in hospital |
| Q38404493 | Impact of polypharmacy on antiretroviral prescription in people living with HIV. |
| Q37613237 | Improved kidney function in patients who switch their protease inhibitor from atazanavir or lopinavir to darunavir |
| Q91495220 | Improving HIV-related care through eHealth |
| Q89766382 | Incidence of chronic obstructive pulmonary disease in people with HIV in Ontario, 1996-2015: a retrospective population-based cohort study |
| Q47118049 | Incidence of diabetes mellitus and factors associated with its development in HIV-positive patients over the age of 50. |
| Q38930578 | Increased brain-predicted aging in treated HIV disease |
| Q41454338 | Increased systemic immune activation and inflammatory profile of long-term HIV-infected ART-controlled patients is related to personal factors, but not to markers of HIV infection severity |
| Q60107924 | Integrating hypertension services at an HIV clinic in Port-au-Prince, Haiti: A report from the field |
| Q98158482 | Interactions of Monocytes, HIV, and ART Identified by an Innovative scRNAseq Pipeline: Pathways to Reservoirs and HIV-Associated Comorbidities |
| Q38767396 | Interventions for Neurocognitive Dysfunction |
| Q60921320 | Kidney disease risk factors associate with urine biomarkers concentrations in HIV-positive persons; a cross-sectional study |
| Q39169127 | Lower Frailty Is Associated with Successful Cognitive Aging Among Older Adults with HIV. |
| Q56984507 | Management of Reduced Bone Mineral Density in HIV: Pharmacological Challenges and the Role of Exercise |
| Q57802126 | Managing HIV infection in patients older than 50 years |
| Q89584749 | Metabolic Syndrome in HIV/HCV Co-infected Patients |
| Q54001419 | Monitoring of kidney function in older people living with HIV. |
| Q89875521 | Mood Disorders and Increased Risk of Noncommunicable Disease in Adults With HIV |
| Q57831581 | Multimorbidity Among Persons Living with Human Immunodeficiency Virus in the United States |
| Q60046427 | Multivariate Computational Analysis of Gamma Delta T Cell Inhibitory Receptor Signatures Reveals the Divergence of Healthy and ART-Suppressed HIV+ Aging |
| Q38832560 | Neurologic Complications in Treated HIV-1 Infection |
| Q36242636 | Non-Communicable Disease Preventive Screening by HIV Care Model |
| Q92191438 | Non-HIV Comorbid Conditions and Polypharmacy Among People Living with HIV Age 65 or Older Compared with HIV-Negative Individuals Age 65 or Older in the United States: A Retrospective Claims-Based Analysis |
| Q49668064 | Noncommunicable Diseases in People Living With HIV: Time for Integrated Care |
| Q94568878 | Noninfectious Comorbidity in the African Cohort Study |
| Q57299014 | Older people with HIV are an essential part of the continuum of HIV care |
| Q57285031 | P2X antagonists inhibit HIV-1 productive infection and inflammatory cytokines IL-10 and IL-1β in a human tonsil explant model |
| Q98779327 | Pathogenesis of Aging and Age-related Comorbidities in People with HIV: Highlights from the HIV ACTION Workshop |
| Q59125345 | Patterns of co-occurring comorbidities in people living with HIV |
| Q30241154 | Peripheral artery disease: epidemiology and global perspectives |
| Q38850845 | Physical activity correlates in people living with HIV/AIDS: a systematic review of 45 studies |
| Q98178022 | Physical activity levels among Malawian adults living with HIV and receiving anti-retroviral therapy |
| Q40446793 | Physical fitness characteristics of active duty US Air Force members with HIV infection |
| Q38760372 | Physical function, grip strength and frailty in people living with HIV in sub-Saharan Africa: systematic review |
| Q40793990 | Plasma Biomarkers of HIV-associated Cognitive Disease. |
| Q99568918 | Platelets function as an acute viral reservoir during HIV-1 infection by harboring virus and T-cell complex formation |
| Q91875387 | Polypharmacy among HIV infected people aged 50 years or older |
| Q37225786 | Polypharmacy in older adults with human immunodeficiency virus infection compared with the general population |
| Q56950513 | Prevalence and correlates of traditional risk factors for cardiovascular disease in a Nigerian ART-naive HIV population: a cross-sectional study |
| Q28391933 | Prevalence and determinants of insufficient work ability in older HIV-positive and HIV-negative workers |
| Q89937334 | Prevalence of Non-AIDS Comorbidities and Factors Associated with Metabolic Complications among HIV-Infected Patients at a Thai Referral Hospital |
| Q60922085 | Prevalence of metabolic syndrome among HIV-positive and HIV-negative populations in sub-Saharan Africa-a systematic review and meta-analysis |
| Q40060225 | Prevalence of self-reported comorbidities in HIV positive and HIV negative men who have sex with men over 55 years-The Australian Positive & Peers Longevity Evaluation Study (APPLES). |
| Q63866060 | Prioritization of risk groups for influenza vaccination in resource limited settings - A case study from South Africa |
| Q46442521 | Projections of non-communicable disease and health care costs among HIV-positive persons in Italy and the U.S.A.: A modelling study |
| Q90191907 | Purinergic Receptors: Elucidating the Role of these Immune Mediators in HIV-1 Fusion |
| Q92626906 | Reduced bone mineral density among HIV infected patients on anti-retroviral therapy in Blantyre, Malawi: Prevalence and associated factors |
| Q40422802 | Relationship Between HIV Infection, Antiretroviral Therapy, Inflammatory Markers, and Cerebrovascular Endothelial Function Among Adults in Urban China. |
| Q51547913 | Respiratory co-morbidities in people with HIV. |
| Q51558627 | Respiratory co-morbidities in people with HIV. |
| Q40132756 | Rilpivirine use in the Swiss HIV cohort study: a prospective cohort study |
| Q36571165 | Role of immune activation in progression to AIDS. |
| Q40048428 | Routine monitoring and assessment of adults living with HIV: results of the British HIV Association (BHIVA) national audit 2015. |
| Q87070862 | Should kidney disease risk affect antiretroviral choice? |
| Q38766464 | Specialist care of older adults with HIV infection in the UK: a service evaluation. |
| Q35748552 | Strong Impact of Smoking on Multimorbidity and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Individuals in Comparison With the General Population |
| Q40140188 | Subclinical atherosclerosis in low Framingham risk HIV patients |
| Q38746270 | Suboptimal primary and secondary cardiovascular disease prevention in HIV-positive individuals on antiretroviral therapy |
| Q64094414 | Substance Use Among Older People Living With HIV: Challenges for Health Care Providers |
| Q88965051 | Supervised Physical Activity and Improved Functional Capacity among Adults Living with HIV: A Systematic Review |
| Q38813848 | Switching regimens in virologically suppressed HIV-1-infected patients: evidence base and rationale for integrase strand transfer inhibitor (INSTI)-containing regimens |
| Q90115110 | Systems analysis and improvement approach to optimize the hypertension diagnosis and care cascade for PLHIV individuals (SAIA-HTN): a hybrid type III cluster randomized trial |
| Q40716958 | T-Cell Activation Independently Associates With Immune Senescence in HIV-Infected Recipients of Long-term Antiretroviral Treatment |
| Q53831638 | Taking the long-view in a personalised approach to HIV care. |
| Q40094624 | Terminal differentiation of T cells is strongly associated with CMV infection and increased in HIV-positive individuals on ART and lifestyle matched controls |
| Q51758448 | The 'COmorBidity in Relation to AIDS' (COBRA) cohort: Design, methods and participant characteristics. |
| Q40678434 | The Framingham function overestimates the risk of ischemic heart disease in HIV-infected patients from Barcelona. |
| Q93010026 | The Growth Hormone Releasing Hormone Analogue, Tesamorelin, Decreases Muscle Fat and Increases Muscle Area in Adults with HIV |
| Q58747834 | The HIV patient profile in 2013 and 2003: Results from the Greek AMACS cohort |
| Q89830236 | The Impact of a Structured, Supervised Exercise Program on Daily Step Count in Sedentary Older Adults With and Without HIV |
| Q90436699 | The association of provider and practice factors with HIV antiretroviral therapy adherence |
| Q35848870 | The cerebrospinal fluid biomarker profile in an HIV-infected subject with Alzheimer's disease |
| Q89500113 | The challenge of HIV treatment in an era of polypharmacy |
| Q40045681 | The changing face of an epidemic: healthy old age with HIV. |
| Q38816195 | The clinical implications of HIV infection and aging |
| Q47646683 | The growing burden of non-communicable disease among persons living with HIV in Zimbabwe. |
| Q40509615 | The impact of comorbidities on costs, utilities and health-related quality of life among HIV patients in a clinical setting in Bogotá. |
| Q52314047 | The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 - 74 years and more than 75 years. |
| Q64105644 | The influence of age-associated comorbidities on responses to combination antiretroviral therapy in older people living with HIV |
| Q40233429 | The nature and consequences of cognitive deficits among tobacco smokers with HIV: a comparison to tobacco smokers without HIV. |
| Q90610834 | The prevalence and risk of non-infectious comorbidities in HIV-infected and non-HIV infected men attending general practice in Australia |
| Q89763403 | The prevalence of selected non-communicable disease risk factors among HIV patients on anti-retroviral therapy in Bushbuckridge sub-district, Mpumalanga province |
| Q59793322 | The systematic development of a complex intervention: HealthMap, an online self-management support program for people with HIV |
| Q38971085 | Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy |
| Q40179340 | Treatment of HIV-infected patients: metabolism, bone, cardiovascular - what is part of routine care? |
| Q61807325 | Trends and predictors of non-communicable disease multimorbidity among adults living with HIV and receiving antiretroviral therapy in Brazil |
| Q90086349 | Understanding Comorbidities and Their Contribution to Predictors of Medical Resource Utilization for an Age- and Sex-Matched Patient Population Living With HIV: Cross-Sectional Study |
| Q95729187 | Validation of a Novel Multivariate Method of Defining HIV-Associated Cognitive Impairment |
| Q51760332 | Virologic failure and mortality in older ART initiators in a multisite Latin American and Caribbean Cohort. |
| Q92082443 | Vitamin D and Phenylbutyrate Supplementation Does Not Modulate Gut Derived Immune Activation in HIV-1 |
Search more.